BMO cuts DXC Technology stock price target on revenue miss By Investing.com

BMO Capital cut DXC Technology’s price target to $10 from $17 while keeping a Market Perform rating, citing a revenue miss in GIS and fiscal 2027 guidance that came in below expectations on both revenue and EBIT margins. DXC’s Q4 fiscal 2026 EPS beat at $0.77 versus $0.70 expected, but revenue missed at $3.13B versus $3.15B consensus, reinforcing concerns about weak demand and execution. The stock trades at $8.91, near its 52-week low of $8.40, after falling 18% over the past week.

Analysis

DXC is less a single-earnings miss story than a credibility and duration story: when management guides below buy-side expectations into fiscal 2027, the market starts discounting that the turnaround is self-funding only if revenue stabilizes first. The GIS softness matters because discretionary services demand is usually the first budget item cut in a slowing CIO spend cycle, so the weakness can persist for multiple quarters even if large-enterprise IT budgets remain intact. That creates a negative feedback loop: lower growth reduces operating leverage, which limits margin recovery, which then suppresses valuation multiples further.

The second-order winner is likely not a direct competitor but higher-quality IT services vendors with more recurring, mission-critical exposure and less project sensitivity. If DXC is seeing pressure in shorter-duration work, that implies deal conversion is weakening in the broader discretionary services bucket, which can temporarily shift spend toward cloud infrastructure, cyber, and software maintenance rather than consulting-heavy implementations. The cleaner names should see relatively better booking resilience even without an industry-wide demand reacceleration.

The main risk/reversal catalyst is execution, not macro: a few quarters of stabilized revenue and even modest margin upside would force a re-rating because the stock is already priced for continued deterioration. Near term, however, the setup remains tactically bearish over the next 1-3 months because estimate revisions are still likely drifting down after a guide below consensus. The contrarian angle is that the stock is close enough to the lows that any incremental evidence of cash generation or buyback support could trigger a sharp short-covering rally, but that would likely be a tradeable bounce rather than a sustained trend change.

Key Decisions for Investors

• Maintain or initiate a tactical short DXC over the next 1-3 months; use rallies toward the $10-11 area as better entry points, with downside toward the low-$8s if revisions continue to reset.
• Pair trade: long a higher-quality IT services/software maintainer basket vs short DXC for 1-2 quarters; the spread should benefit if discretionary project spend stays weak while recurring-revenue names hold up better.
• Avoid long exposure until management proves two consecutive quarters of flat-to-positive organic revenue; the risk/reward remains poor because multiple expansion is capped without top-line stabilization.
• For options traders, consider DXC put spreads 1-2 quarters out to express bearish conviction while limiting premium decay; this fits a thesis of slow deterioration rather than immediate collapse.
• If DXC can reclaim the $10 level on volume after earnings-related selling, cover part of shorts into strength; that would likely reflect technical covering more than a fundamental inflection.